Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Raw Materials (2017 - 2025)

Nephros (NEPH) has 9 years of Raw Materials data on record, last reported at $209000.0 in Q3 2025.

  • For Q3 2025, Raw Materials fell 43.36% year-over-year to $209000.0; the TTM value through Sep 2025 reached $209000.0, down 43.36%, while the annual FY2024 figure was $354000.0, 8.59% up from the prior year.
  • Raw Materials reached $209000.0 in Q3 2025 per NEPH's latest filing, down from $258000.0 in the prior quarter.
  • Across five years, Raw Materials topped out at $1.1 million in Q1 2022 and bottomed at $209000.0 in Q3 2025.
  • Average Raw Materials over 5 years is $555157.9, with a median of $422000.0 recorded in 2022.
  • Peak YoY movement for Raw Materials: soared 151.51% in 2021, then crashed 57.71% in 2023.
  • A 5-year view of Raw Materials shows it stood at $807000.0 in 2021, then tumbled by 47.71% to $422000.0 in 2022, then dropped by 22.75% to $326000.0 in 2023, then rose by 8.59% to $354000.0 in 2024, then tumbled by 40.96% to $209000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Raw Materials were $209000.0 in Q3 2025, $258000.0 in Q2 2025, and $328000.0 in Q1 2025.